Nature Reviews Urology

Papers
(The H4-Index of Nature Reviews Urology is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything215
Texture analysis for patient selection202
Single-cell and spatial sequencing of kidney cancer149
Human-relevant urothelial model provides insight into infection strategies and host response135
Krause corpuscles act as genital vibration detectors108
Semen quality recovery following COVID-19100
PARP inhibitors plus enzalutamide to treat mCRPC83
High-dose chemotherapy for relapsed testicular germ cell tumours79
Urine microbiota differ in bladder cancer77
Considering urology in a planetary context76
Preclinical models of bladder cancer: BBN and beyond73
Time for women-centred gynaecology73
Advancing the state of the art in congenital obstructive uropathy69
A clinical guide to rare male sexual disorders69
Micro-ultrasound for prostate cancer65
Symptoms and subtypes of patients with lower urinary tract dysfunction — insights from the Symptoms of Lower Urinary Tract Dysfunction Research Network64
Proteomic-based analysis of testicular interstitial fluid61
FOXA2–KIT-driven lineage plasticity in NEPC58
Overcoming antibiotic resistance in complicated UTI55
A new text message-based platform for self-management of patients with IC/BPS55
Microfluidic sperm selection53
What happens in Vegas … shapes the future of urology53
Madrid plays host to a celebration of urology53
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer52
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations52
Promise without practice — charting the path forward for bladder cancer biomarkers51
Leveraging generative AI to enhance doctor–patient communication51
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence47
Metaverse in surgery — origins and future potential47
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers47
Pembrolizumab + axitinib beyond first-line therapy for mRCC46
COVID can’t kill CopMich collaboration44
A non-invasive assay for UTUC diagnosis44
Vaccination to prevent untreatable gonorrhoea44
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology42
Personalized 3D models for prostate cancer surgery42
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications41
Efficacy of the Revi system in treating urgency urinary incontinence41
PEACEing together prostate cancer therapy39
EMUC25: shaping tomorrow’s uro-oncology care39
Resolving the puzzle of same-sex sexual interactions39
0.062816143035889